News
Pacira BioSciences boasts a strong balance sheet with $495 million in cash and a new $300 million stock buyback authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback